Invention Grant
US08426359B2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
失效
丝氨酸蛋白酶抑制剂，特别是HCV NS3-NS4A蛋白酶
- Patent Title: Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
- Patent Title (中): 丝氨酸蛋白酶抑制剂，特别是HCV NS3-NS4A蛋白酶
-
Application No.: US12265125Application Date: 2008-11-05
-
Publication No.: US08426359B2Publication Date: 2013-04-23
- Inventor: Kevin M. Cottrell , Robert B. Perni , Janos Pitlik , Wayne C. Schairer
- Applicant: Kevin M. Cottrell , Robert B. Perni , Janos Pitlik , Wayne C. Schairer
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Lisa A. Dixon; Susan C. Kelly
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The present invention relates to compounds of formula I: or a pharmaceutically acceptable salts thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are useful as antiviral agents. The invention further relates to pharmaceutically acceptable compositions comprising said compounds either for ex vivo use or for administration to a patient suffering from HCV infection and to processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a pharmaceutical composition comprising a compound of this invention.
Public/Granted literature
- US20090291902A1 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE Public/Granted day:2009-11-26
Information query
IPC分类:
